Seeking Alpha

In a major victory for the generic pharmaceuticals industry, the Supreme Court yesterday ruled...

In a major victory for the generic pharmaceuticals industry, the Supreme Court yesterday ruled that patients can't sue firms over copycat drugs that are allegedly unsafe. The court quashed a New Hampshire jury's decision to award $21M to a woman who developed a debilitating skin disease after she took a generic version of the pain treatment sulindac made by a unit of India's Sun Pharmaceutical.
Comments (5)
  • Definition of copycat?
    Is ANY generic manufacturer a copycat?
    25 Jun 2013, 06:35 AM Reply Like
  • "...patients can't sue firms over copycat drugs that are allegedly unsafe."

     

    Did it say it was unsafe? Did she know it was unsafe? Sounds like a labelling issue.
    25 Jun 2013, 08:00 AM Reply Like
  • From the larger story: "Generic drug makers now have a responsibility to mirror the safety label of the brand-name company and to alert the F.D.A. whenever they learn of an adverse event related to their products. It is then up to the agency to decide whether to change the label.

     

    Critics have said the current system works too slowly, and does not account for situations when problems arise with a drug after the brand-name manufacturer has left the market."

     

    So, if you're taking a generic because the brand-name is no longer available (or you can't afford the brand-name) and the generic causes harm, tough! These firms are no longer responsible for careless formulation.

     

    Profits over people.
    25 Jun 2013, 09:11 AM Reply Like
  • I thought corporations were people... :)
    25 Jun 2013, 01:56 PM Reply Like
  • Wow!.. what that means is these generic companies can get away with murder and they are untouchable. There is something wrong with this picture. I know someone who works with Activis used to be Watson who bought out the Canadian company Arrow / Cobalt pharmaceuticals who say that some drugs go thru this tests and fail stability and other tests at R&D and prerelease and they use False Data to get FDA approval.. just to get the products into the market...
    25 Jun 2013, 01:57 PM Reply Like
DJIA (DIA) S&P 500 (SPY)